Telomir Pharmaceuticals News

Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust

Feb 15 16:15 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Bay Shore Trust

Feb 8 18:06 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Tuck Talhia

Feb 8 18:01 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Fuentes Nathen

Feb 8 17:56 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Jerman Michael Allen

Feb 8 17:56 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director McColl Hugh III

Feb 8 17:51 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director EAGLE CRAIG

Feb 8 17:51 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Nicholoudis Christos

Feb 8 17:41 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Chapman Christopher C JR

Feb 8 17:41 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Kroenig Bradley

Feb 8 17:36 ET

Telomir Pharmaceuticals | D: Filing D

Apr 3, 2023 04:05 ET